Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.

This three year fellowship is aimed at supporting the brightest and most promising scientists in their early research careers at the University of Oxford.

The award will support his study into autophagy; the intracellular degradation system which recycles damaged cellular components. Decreased autophagy levels have been associated with age-related diseases such as neurodegeneration and cancer. Hanlin aims to elucidate a novel autophagy signaling pathway and identify novel drug targets within this pathway to increase autophagy levels to achieve healthier ageing.

Commenting on his award, Hanlin said "Human ageing is a very complex process and associated with many severe diseases. Autophagy plays a critical role in regulating cell homeostasis and senescence. I am happy and grateful to be awarded this early-career fellowship. It will help me gain a deeper insight into this novel autophagy and ageing pathway, which might help unveil the ageing mystery.”

Hanlin will be based primarily within the Kennedy Institue under the supervision of Prof. Katja Simon.

Funding Body

elysium-logo.jpg

Similar stories

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

Kennedy researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

New drug offers hope for people with hand osteoarthritis

A new study, published in Science Translational Medicine by researchers at the University of Oxford has identified that Talarozole, a drug that is known to increase retinoic acid, was able to prevent osteoarthritis (OA) in disease models.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

NIHR funding for musculoskeletal and inflammatory disease research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.